Geode Capital Management’s Cyclerion Therapeutics CYCN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $95.3K | Buy |
|
|||||
2025
Q1 | $78.1K | Sell |
|
|||||
2024
Q4 | $102K | Sell |
|
|||||
2024
Q3 | $87.5K | Sell |
|
|||||
2024
Q2 | $77.5K | Buy |
|
|||||
2024
Q1 | $103K | Buy |
|
|||||
2023
Q4 | $105K | Buy |
|
|||||
2023
Q3 | $105K | Buy |
|
|||||
2023
Q2 | $122K | Buy |
|
|||||
2023
Q1 | $257K | Buy |
|
|||||
2022
Q4 | $385K | Buy |
|
|||||
2022
Q3 | $502K | Buy |
|
|||||
2022
Q2 | $314K | Sell |
|
|||||
2022
Q1 | $647K | Buy |
|
|||||
2021
Q4 | $973K | Buy |
|
|||||
2021
Q3 | $1.51M | Buy |
|
|||||
2021
Q2 | $1.5M | Sell |
|
|||||
2021
Q1 | $1.36M | Buy |
|
|||||
2020
Q4 | $1.33M | Buy |
|
|||||
2020
Q3 | $2.15M | Buy |
|
|||||
2020
Q2 | $1.87M | Sell |
|
|||||
2020
Q1 | $855K | Buy |
|
|||||
2019
Q4 | $817K | Buy |
|
|||||
2019
Q3 | $2.98M | Buy |
|
|||||
2019
Q2 | $2.76M | Buy |
|